• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 4. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

Professional Introduction to 2-(4-methyl-1,3-thiazol-2-yl)ethan-1-amine dihydrochloride (CAS No. 1134723-32-2)

2-(4-methyl-1,3-thiazol-2-yl)ethan-1-amine dihydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 1134723-32-2, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This compound belongs to the thiazole derivatives, a class of heterocyclic compounds known for their diverse biological activities and therapeutic potential. The structural framework of 2-(4-methyl-1,3-thiazol-2-yl)ethan-1-amine dihydrochloride incorporates a thiazole ring substituted with a methyl group at the 4-position and an amine functional group at the 2-position, further modified by an ethyl chain terminated with a hydrochloride salt form. This unique configuration imparts distinct chemical and pharmacological properties, making it a subject of considerable interest in drug discovery and development.

The thiazole core is a privileged scaffold in medicinal chemistry, widely recognized for its role in numerous bioactive molecules. Its aromaticity, combined with the sulfur and nitrogen atoms within the ring, allows for versatile interactions with biological targets. In particular, 2-(4-methyl-1,3-thiazol-2-yl)ethan-1-amine dihydrochloride has garnered attention due to its potential as an intermediate or lead compound in the synthesis of novel therapeutic agents. The presence of the amine group not only influences its solubility and stability but also opens avenues for further derivatization, enabling chemists to tailor its properties for specific applications.

Recent advancements in computational chemistry and molecular modeling have enhanced our understanding of how 2-(4-methyl-1,3-thiazol-2-yl)ethan-1-amine dihydrochloride interacts with biological macromolecules. Studies suggest that its structural features may facilitate binding to enzymes or receptors involved in critical metabolic pathways. For instance, modifications to the thiazole ring can modulate electronic properties, affecting reactivity and binding affinity. The methyl substituent at the 4-position appears to play a role in fine-tuning steric hindrance, which is crucial for optimizing drug-like characteristics such as lipophilicity and metabolic stability.

One of the most compelling aspects of 2-(4-methyl-1,3-thiazol-2-yl)ethan-1-amine dihydrochloride is its potential application in addressing unmet medical needs. Emerging research indicates that derivatives of this compound may exhibit antimicrobial, anti-inflammatory, or anticancer properties. The hydrochloride salt form enhances solubility, which is a critical factor in formulation development for oral or injectable therapies. Furthermore, the stability imparted by the salt form ensures that the compound remains viable throughout storage and transportation, maintaining its efficacy for clinical use.

The pharmaceutical industry has long been intrigued by thiazole derivatives due to their broad spectrum of biological activities. 2-(4-methyl-1,3-thiazol-2-yl)ethan-1-amine dihydrochloride represents a promising candidate for further investigation into its pharmacological profile. Preclinical studies have begun to explore its interactions with target proteins and its potential side effect profile. These investigations are essential for assessing whether this compound can transition from laboratory research to clinical trials without significant safety concerns.

The synthesis of 2-(4-methyl-1,3-thiazol-2-y l)ethan -1-am ine dihydroch lor ide involves multi-step organic reactions that highlight modern synthetic methodologies. Advanced techniques such as transition metal catalysis have been employed to streamline the process while maintaining high yields and purity standards. The ability to produce this compound efficiently is crucial for large-scale applications in drug development programs. Additionally, green chemistry principles are being integrated into synthetic routes to minimize environmental impact and improve sustainability.

In conclusion, 2-(4-methyl -1 ,3 -thia z ol - 2 -y l)et han - 1 -a min e dihydroch lor ide (CAS No . 11347 23 -32 - 2) stands out as a valuable asset in pharmaceutical research due to its structural complexity and potential therapeutic applications . Ongoing studies continue to unravel its biological significance , paving the way for innovative treatments across various disease domains . As our understanding of molecular interactions evolves , compounds like this one will undoubtedly play a pivotal role in shaping future medical advancements .

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)